Allograft and overall survival of patients with posttransplant skin cancer

Dermatologic Surgery

Volumn 37, Issue 2, 2011, Pages 183-191

  Christenson, Leslie J ^a,b   Cherikh, Wida S ^c   Otley, Clark C ^a,b   Salasche, Stuart J ^b,c   Kauffman, H Myron ^d  

^a MAYO CLINIC   (United States)

^b International Transplant Skin Cancer Collaborative   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d UNITED NETWORK FOR ORGAN SHARING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN; DACLIZUMAB; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; DATA BASE; DEATH; DISEASE ASSOCIATION; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; POSTTRANSPLANT NONMELANOMA SKIN CANCER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SKIN CANCER; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; FEMALE; GRAFT SURVIVAL; HUMANS; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS; SURVIVAL RATE; UNITED STATES; YOUNG ADULT;

EID: 79951958011     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2010.01848.x     Document Type: Article

References (31)

1. Euvrard S, Kanitakis J, Claudy A., Skin cancers after organ transplantation. N Engl J Med 2003; 348: 1681-91. (Pubitemid 36459475)
2. Berg D, Otley CC., Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002; 47: 1-17.
3. Euvrard S, Kanitakis J, Pouteil-Noble C, et al,. Aggressive squamous cell carcinomas in organ transplant recipients. Transplant Proc 1995; 27: 1767-8.
4. Adamson R, Obispo E, Dychter S, et al,. High incidence and clinical course of aggressive skin cancer in heart transplant patients: a single-center study. Transplant Proc 1998; 30: 1124-6. (Pubitemid 28309508)
5. Pollard JD, Hanasono MM, Mikulec AA, et al,. Head and neck cancer in cardiothoracic transplant recipients. Laryngoscope 2000; 110: 1257-61. (Pubitemid 30626089)
6. Veness MJ, Quinn DI, Ong CS, et al,. Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience. Cancer 1999; 85: 1758-64. (Pubitemid 29169677)
7. Martinez JC, Otley CC, Transplant-Skin Cancer Collaborative et al. Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study. Arch Dermatol 2003; 139: 301-6. (Pubitemid 36330577)
8. Sloan GM, Cole P, Wilson RE., Risk indicators of de novo malignancy in renal transplant recipients. Transplant Proc 1977; 9: 1129-32.
9. Sheil AG, Mahoney JF, Horvath JS, et al,. Cancer and survival after cadaveric donor renal transplantation. Transplant Proc 1979; 11: 1052-4. (Pubitemid 9173628)
10. Herrero JI, Espana A, Quiroga J, et al,. Nonmelanoma skin cancer after liver transplantation: study of risk factors. Liver Transplant 2005; 11: 1100-6. (Pubitemid 41341760)
11. Saigal S, Norris S, Muiesan P, et al,. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transplant 2002; 8: 482-7. (Pubitemid 34520778)
12. Otley CC, Cherikh WS, Salasche SJ, et al,. Skin cancer in organ transplant recipients: effect of pretransplant end-organ disease. J Am Acad Dermatol 2005; 53: 783-90.
13. Park YH, Min SK, Lee JN, et al,. Comparison of survival probabilities for living-unrelated versus cadaveric renal transplant recipients. Transplant Proc 2004; 36: 2020-2. (Pubitemid 39424311)
14. West JC, Bisordi JE, Squiers EC, et al,. Length of time on dialysis prior to renal transplantation is a critical factor affecting patient survival after allografting. Transplant Int 1992; 5 (Suppl 1): S148-50.
15. Meier-Kriesche HU, Kaplan B., Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis. Transplantation 2002; 74: 1377-81. (Pubitemid 35379540)
16. Wu J, Chen J, Wang Y, et al,. Impact of acute rejection episodes on long-term renal allograft survival. Chin Med J (Engl) 2003; 116: 1741-5. (Pubitemid 38008252)
17. Terasaki PI, Gjertson DW, Cecka JM, et al,. Significance of the donor age effect on kidney transplants. Clin Transplant 1997; 11: 366-72. (Pubitemid 27460429)
18. Matinlauri IH, Nurminen MM, Hockerstedt KA, Isoniemi HM., Risk factors predicting survival of liver transplantation. Transplant Proc 2005; 37: 1155-60. (Pubitemid 40590822)
19. Moore DE, Feurer ID, Speroff T, et al,. Impact of donor, technical, and recipient risk factors on survival and quality of life after liver transplantation. Arch Surg 2005; 140: 273-7. (Pubitemid 41001820)
20. Neumann UP, Berg T, Bahra M, et al,. Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up. Transplantation 2004; 77: 226-31. (Pubitemid 38155751)
21. Kirklin JK, Pambukian SV, McGiffin DC, Benza RL., Current outcomes following heart transplantation. Semin Thorac Cardiovasc Surg 2004; 16: 395-403. (Pubitemid 40089672)
22. Hartevelt MM, Bavinck JN, Kootte AM, et al,. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 1990; 49: 506-9. (Pubitemid 20110465)
23. Ramsay HM, Fryer AA, Hawley CM, et al,. Non-melanoma skin cancer risk in the Queensland renal transplant population. Br J Dermatol 2002; 147: 950-6. (Pubitemid 35365443)
24. Webb MC, Compton F, Andrews PA, Koffman CG., Skin tumours posttransplantation: a retrospective analysis of 28 years' experience at a single centre. Transplant Proc 1997; 29: 828-30.
25. Bouwes Bavinck JN, Hardie DR, Green A, et al,. The risk of skin cancer in renal transplant recipients in Queensland, Australia: a follow-up study. Transplantation 1996; 61: 715-21. (Pubitemid 26097231)
26. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C., Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4: 905-13. (Pubitemid 38745589)
27. Espana A, Martinez-Gonzalez MA, Garcia-Granero M, et al,. A prospective study of incident nonmelanoma skin cancer in heart transplant recipients. J Invest Dermatol 2000; 115: 1158-60. (Pubitemid 32037467)
28. Scotto J, Fears TR, Fraumeni JF., Incidence of nonmelanoma skin cancer in the United States. Bethesda (MD): Department of Health and Human Services (US), Public Health Service, National Institutes of Health, National Cancer Institute; 1983. 113 pp. (NIH publication; no. 83-2433).
29. Giles GG, Marks R, Foley P., Incidence of non-melanocytic skin cancer treated in Australia. Br Med J 1988; 296: 13-7. (Pubitemid 18025276)
30. Euvrard S, Kanitakis J, Pouteil-Noble C, et al,. Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol 1995; 33: 222-9.
31. Lindelof B, Sigurgeirsson B, Gabel H, Stern RS., Incidence of skin cancer in 5,356 patients following organ transplantation. Br J Dermatol 2000; 143: 513-9.